# Comparison of the Therapeutic Effects of VR and VR + Metformin in the Treatment of Cesarean Section Scar Defect

> **NCT05205317** · NA · RECRUITING · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 100 (estimated)

## Conditions studied

- Defect

## Interventions

- **DRUG:** Metformin Hydrochloride Sustained-release Tablets
- **PROCEDURE:** Vaginal repair

## Key facts

- **NCT ID:** NCT05205317
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-15
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05205317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05205317, "Comparison of the Therapeutic Effects of VR and VR + Metformin in the Treatment of Cesarean Section Scar Defect". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05205317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*